Yiheng Capital »

Passage Bio shares owned by Yiheng Capital

Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by Yiheng Capital from 13F filings

Historical chart of Yiheng Capital investment in Passage Bio

Tip: Access up to 7 years of quarterly data

All positions including Passage Bio held by Yiheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Passage Bio by Yiheng Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $405k 34k 11.80

More positions owned by Yiheng Capital

Astera Labs Put Option (ALAB)
Noah Hldgs Spon Ads (NOAH)
Bilibili Spons Ads Rep Z (BILI)
Jd.com Spon Ads Cl A (JD)
New Oriental Ed & Technology Spon Adr (EDU)
H World Group Sponsored Ads (HTHT)
Atre Sponsored Ads (RERE)
ViaSat Put Option (VSAT)
Dbv Technologies S A Sponsored Ads (DBVT)
Ul Solutions Class A Com Shs Put Option (ULS)
Pony Ai Sponsored Ads (PONY)
Acm Resh Com Cl A (ACMR)
Miragen Therapeutics (VRDN)
Kymera Therapeutics (KYMR)
Silvaco Group (SVCO)

View all positions for Yiheng Capital

Top funds holding Passage Bio

Lynx1 Capital Management
Vestal Point Capital
Vanguard Group
Eversept Partners
Renaissance Technologies
Erste Asset Management GmbH
OrbiMed Advisors
Yiheng Capital
Geode Capital Management
BlackRock
Acadian Asset Management
Bridgeway Capital Management
Citadel Advisors
Northern Trust
Quadrature Capital

View all funds holding Passage Bio